RLYP Insider Trading Activity and SEC Form 4 Filings
RLYP insider trading summary
No open-market insider purchases or sales of Relypsa Inc (RLYP) have been reported on SEC Form 4 in the past 12 months.
Latest RLYP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 17, 2016 | James D Dondero | 10% Owner | Buy | $16K (500 @ $31.92) |
| Aug 16, 2016 | Monte Montgomery | Chief Accounting Officer | Sell | $16K (510 @ $31.92) |
| Aug 11, 2016 | James D Dondero | 10% Owner | Sell | $1.2M (37,000 @ $31.96) |
| Jul 25, 2016 | OrbiMed Capital GP IV LLC | 10% Owner | Sell | $11.0M (343,600 @ $31.98) |
| Jul 25, 2016 | Samuel D Isaly | 10% Owner | Sell | $11.0M (343,600 @ $31.98) |
| Jul 25, 2016 | Orbimed Advisors LLC | 10% Owner | Sell | $11.0M (343,600 @ $31.98) |
| Jul 22, 2016 | OrbiMed Capital GP IV LLC | 10% Owner | Sell | $118.4M (3,700,000 @ $32.00) |
| Jul 22, 2016 | Samuel D Isaly | 10% Owner | Sell | $118.4M (3,700,000 @ $32.00) |
| Jul 22, 2016 | Orbimed Advisors LLC | 10% Owner | Sell | $118.4M (3,700,000 @ $32.00) |
| Jun 7, 2016 | David W J McGirr | Director | Sell | $20K (1,013 @ $19.34) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.